Physician profile
Charles Scott Hultman
NPI 1245324243
$70,496.86
in general payments reported to CMS, 2019-2025
22 companies · $1,582 in 2025
The $1,582 reported for 2025 was more than what 80% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $398 · 2021: $3,410 · 2022: $23K · 2023: $36K · 2024: $5,683 · 2025: $1,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Food and Beverage: $4,406 · Honoraria: $4,250 · Travel and Lodging: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,125.04 |
| Food and Beverage | $4,405.67 |
| Honoraria | $4,250.00 |
| Travel and Lodging | $1,261.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $39,705.00 | 2019-2025 | Recell, Cohealyx, Permeaderm |
| Vericel Corporation | $24,521.06 | 2021-2024 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Kerecis Limited | $1,016.22 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Abbvie INC. | $792.46 | 2023-2025 | |
| Smith+Nephew, INC. | $776.88 | 2020-2025 | Stravix, Grafix Pl, Oasis |
| Tela Bio, INC. | $669.68 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $480.54 | 2022 | |
| Integra Lifesciences Corporation | $470.36 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Lifenet Health | $365.32 | 2024-2025 | Theragenesis Wound Matrix |
| Polymedics Innovations INC. | $326.04 | 2025 | |
| Davol INC. | $321.12 | 2023-2025 | Phasix Mesh |
| Sientra, INC. | $219.41 | 2022 | |
| Urgo Medical North America, LLC | $207.34 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Motiva USA, LLC | $170.33 | 2025 | |
| Myriad Genetic Laboratories, INC. | $122.51 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $99.13 | 2019 | |
| Stryker Corporation | $56.36 | 2020 | |
| Next Science LLC | $47.01 | 2023 | Surgx, Blastx, Xperience |
| Ethicon US, LLC | $44.71 | 2025 | Vistaseal |
| Sanara Medtech INC. | $31.24 | 2024 | Celleraterx |
| Aroa Biosurgery Incorporated | $31.17 | 2024 | |
| Acera Surgical, INC. | $22.97 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Hultman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.